Drawing for DS INPHARMATICS

USPTO serial 88567150

DS INPHARMATICS

Reviewed by CopyMark Law Group

Reg. 6170784Status 700Renewal
Filing date
Status date
Registration date
Oct 6, 2020
Examiner
MCMORROW, RONALD G
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DS INPHARMATICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander T. Bara

Alexander T. Bara IPHORGAN LTD.195 ARLINGTON HEIGHTS ROADSUITE 125BUFFALO GROVE, IL 60089

Goods and services

ClassDescriptionStatusFirst use
035Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; consulting services in the field of commercial administration of the licensing of pharmaceutical products of othersACTIVEJan 1, 2019
042Providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; technological due diligence consulting in the field of pharmaceutical technologyACTIVEJan 1, 2019
045Regulatory compliance consulting in the fields of pharmaceutical development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services in the field of pharmaceutical licensing requirementsACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 6, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 4, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 3, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 27, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 25, 2020IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Aug 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 13, 2020IUFFUSE AFFIDAVIT FAILED FORMALITIES—
Aug 12, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 30, 2020IUAFUSE AMENDMENT FILED—
Jul 30, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 23, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2020ALIEASSIGNED TO LIE—
Mar 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2019DOCKASSIGNED TO EXAMINER—
Aug 23, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance